The mimetics of antiadhesive peptides as the inhibitors of Mycibacterium kansasii phagocytosis

Peptides

Volumn 26, Issue 9, 2005, Pages 1543-1549

  Siemion, Ignacy Z ^a   Gawłowska, Monika ^a   Ślepokura, Katarzyna ^a   Biernat, Monika ^a   Wieczorek, Zbigniew ^b  

^a UNIVERSITY OF WROC AW   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Antiadhesive peptides; Guanidino acids; Mycobacteria phagocytosis; Peptide mimetics

Indexed keywords

ANTIADHESIVE PEPTIDE; CARBOXYL GROUP; GUANIDINE; OMEGA GUANIDINO ACID; PEPTIDE DERIVATIVE; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG DETERMINATION; MYCOBACTERIUM KANSASII; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; STRUCTURE ANALYSIS; X RAY ANALYSIS;

AMIDINES; AMINO ACIDS; CRYSTALLOGRAPHY, X-RAY; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCINE; GUANIDINE; HUMANS; LEUKOCYTES, MONONUCLEAR; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR MIMICRY; MYCOBACTERIUM KANSASII; OLIGOPEPTIDES; PHAGOCYTOSIS;

CORYNEBACTERINEAE;

EID: 23844442250     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2005.02.009     Document Type: Article

References (27)

1. L. Alig, A. Edenhofer, P. Hadvary, M. Hurzeler, D. Knopp, and M. Muller Low molecular weight, non-peptide fibrinogen receptor antagonists J Med Chem 35 1992 4393 4407
2. E.C. Boyle, and B.B. Finlay Bacterial pathogenesis: exploiting cellular adherence Curr Opin Cell Biol 15 2003 633 639
3. R.C. Clark, and J.S. Reid Acta Cryst A51 1995 887
4. W.S. Craig, S. Cheng, D.G. Mullen, J. Blevitt, and M.D. Pierschbacher Concept and progress in the development of RGD-containing peptide pharmaceuticals Biopolymers 37 1995 157 175
5. CrysAlis RED, ver. 1.171 Oxford Diffraction Poland, 1995-2003.
6. M.S. Egbertson Non-peptide fibrinogen receptor antagonists 2. Optimization of a tyrosine template as a mimic for Arg-Gly-Asp J Med Chem 37 1994 2537 2551
7. Gawłowska M, Ślepokura K, Wieczorek Z, Siemion IZ. A new approach to the therapy of diseases induced by Mycobacteria invasion. Acta Pharmaceut Polon, in press.
8. Z.A. Hamburger, M.S. Brown, R.R. Isberg, and P.J. Bjorkman Crystal structure of invasin: a bacterial integrin-binding protein Science 286 1999 291 295
9. G.D. Hartman Non-peptide fibrinogen receptor antagonists 1. Discovery and design of exosite inhibitors J Med Chem 35 1992 4642 4646
10. P.J. Hippenmeyer, P.G. Ruminski, J.G. Rico, H.S. Lu, and D.W. Griggs Adenovirus inhibition by peptidomimetic integrin antagonists Antiviral Res 55 2002 169 178
11. G. Holzemann Recent advances in avb3 integrin inhibitors Drugs 4 2001 72 81
12. International Tables for X-ray Crystallography, vol. IV, Kynoch Press, Birmingham, 1974.
13. R.R. Isbery, and VN.G. Tran Binding and internalization of microorganisms by integrin receptors Trends Microbiol 2 1994 10 14
14. J. Kapfhammer, and H. Müller Guanidosäuren und Guanidopeptide Z Physiol Chem 225 1934 1 12
15. J.R. Kerr Cell adhesion molecules in the pathogenesis of and host defence against microbial infection J Clin Pathol, Mol Pathol 52 1999 220 230
16. D.J. Leahy, and H.P. Anknies 2.0 a crystal structure of the four domain segment of humane fibronectin encompassing the RGD loop and synergy region Cell 84 1996 155 164
17. M. Miyashita, M. Akamatsu, Y. Hayashi, and T. Oeno Three-dimensional quantitative structure-activity relationship analyses of RGD mimetics as fibrinogen receptor antagonists Bioorg Med Chem Lett 10 2000 859 863
18. I. Ojima, S. Chakravatry, and Q. Dong Antithrombotic agents: from RGD to peptide mimetics Bioorg Med Chem 3 1995 337 360
19. U. Schwartz-Linek, M. Hook, and I.R. Potts The molecular basis of fibronectin-mediated bacterial adherence to host cells Mol Microbiol 52 2004 631 641
20. Sheldrick GM. SHELXS-97 Program for the solution of crystal structures. University of Göttingen, Germany.
21. Sheldrick GM. SHELXL-97. Program for the refinement of crystal structures. University of Göttingen, Germany.
22. I.Z. Siemion, M. Gawłowska, K. Krajewski, I. Strug, and Z. Wieczorek Analogs of RGDVY and GRGD peptides inhibit Mycobacterium kansasii phagocytosis Peptides 24 2003 1109 1115
23. I.Z. Siemion, M. Gawłowska, and Z. Wieczorek Mycobacterium kansasii phagocytosis inhibited by the oligopeptides derived from systemin, cecropin A and BRCT-1 protein sequences Polish J Chem 78 2004 1073 1079
24. I.Z. Siemion, and Z. Wieczorek Antiadhesive peptides as the of Mycobacterium kansasii phagocytosis inhibitors Peptides 24 2003 623 628
25. A. Stavrakoudis, G. Bizos, D. Eleftheriadis, A. Kouki, E. Panou-Pomonis, and M. Sakarellos-Daitsiotis A three-residue cyclic scaffold of non-RGD containing peptide analogues as platelet aggregation inhibitors: design, synthesis, and structure-function relationships Biopolymers 56 2001 20 26
26. 3 in complex with an Arg-Gly-Asp ligand Science 296 2002 151 155
27. XP-Interactive molecular graphics, ver. 5.1, Bruker Analytical X-ray Systems, 1998.